N. Aziizi et al. / Journal of Molecular Liquids xxx (2014) xxx–xxx
5
Fig. 3. Scanning electron microscopy (SEM) images of (Fe3O4) nanoparticles.
163 5.2. Selected data
5.2.8. (Table 1, 4l) 2-(2,4-dichlorophenyl)-1,4,5-triphenyl-1H-imidazole
206
1H NMR, 500 MHz (DMSO-d6) δ 7.12–7.31 (m, 13H), 7.42 (dd, J = 7.9, 207
1.5 Hz, 1H), 7.50 (d, J = 7.5 Hz, 2H), 7.60–7.62 (m, 2H): 13C NMR 208
(125 MHz, DMSO-d6) δ 127.2, 127.4, 127.9, 128.9, 129.0, 129.3, 129.4, 209
129.5, 129.7, 130.2, 130.9, 131.5, 135.7, 136.3, 137.7, 144.2, MS (m/z, %): 210
OOF
164 5.2.1. (Table 1, 4b) 2-(4-Chlorophenyl)-1,4,5-triphenyl-1H-imidazole
165
1H NMR, 500 MHz (CDCl3) δ 7.08 (d, J = 6.9 Hz, 2H), 7.15 (d, J =
166 6.9 Hz, 2H), 7.26–7.33 (m, 11H), 7.42 (d, J = 7.8 Hz, 2H), 7.63 (d, J =
167 8.7 Hz, 2H): 13C NMR (125 MHz, CDCl3/DMSO-d6) δ 127.4, 127.9,
168 128.6, 128.7, 128.8, 129.1, 129.7, 130.4, 130.7, 131.5, 136.9, 145.9: MS
169 (m/z, %): 406 (M+), 165 (100).
441 (M+), 165 (100).
211
5.2.9. (Table 1, 4s) 2-(naphthalene-3-yl)-1,4,5-triphenyl-1H-imidazole
212
1H NMR, 500 MHz (CDCl3) δ 7.12 (d, J = 7.12 Hz, 2H), 7.19 (d, J = 213
7.4 Hz, 2H), 7.24–7.35 (m, 9H), 7.45–7.50 (m, 2H), 7.56 (d, J = 8.4 Hz, 214
1H), 7.68–7.72 (m, 4 H), 7.79 (d, J = 7.8 Hz, 1H), 8.00 (s, 1H): 13C 215
NMR (125 MHz, CDCl3) δ 126.6, 126.7, 127.0, 127.3, 128.0, 128.1, 216
128.5, 128.6, 131.5, 131.6, 133.3, 133.4, 137.3, 147.1: MS (m/z, %): 422 217
170 5.2.2. (Table 1, 4c) 2-(4-bromophenyl)-1,4,5-triphenyl-1H-imidazole
171
1H NMR, 500 MHz (DMSO-d6) δ 7.16–7.33 (m, 15H), 7.48 (d, J =
172 7.08 Hz, 4H): 13C NMR (125 MHz, CDCl3/DMSO-d6) δ 122.7, 127.2,
173 127.4, 129.0, 129.3, 129.5, 129.7, 130.4, 131.0, 131.9, 132.0, 132.4,
174 135.1, 137.2, 137.9, 145.8; MS (m/z, %): 450 (M+, 100).
(M+, 100).
218
175 5.2.3. (Table 1, 4d) 4-(1,4,5-triphenyl-1H-imidazole-2-yl)phenol
176
5.2.10. (Table 1, 4r) 2-(naphthalene-1-yl)-1,4,5-triphenyl-1H-imidazole 219
1H NMR, 500 MHz (CDCl3) δ 6.93 (d, J = 7.0 Hz, 2H), 7.00–7.09 (m, 220
3 H), 7.26–7.52 (m, 12 H), 7.72 (dd, J = 7.2, 1.2 Hz, 2H), 7.83 (t, J = 221
7.4 Hz, 2 H), 8.24 (dd, J = 6.8, 2.2 Hz, 1H): 13C NMR (125 MHz, CDCl3) 222
δ 125.0, 126.4, 126.6, 127.1, 127.9, 128.2, 128.3, 128.4, 128.5, 128.6, 223
128.9, 129.0, 129.8, 129.9, 130.3, 131.1, 131.5, 133.2, 134.0, 134.8, 224
1H NMR, 500 MHz (CDCl3 + DMSO-d6) δ 6.15 (d, J = 8.4 Hz, 2H),
177 6.55–6.79 (m, 15H), 6.99 (d, J = 7.5 Hz, 2H), 8.84 (brs, OH, 1H): 13C
178 NMR (125 MHz, CDCl3/DMSO-d6) δ 115.2, 126.7, 127.1, 128.1, 128.2,
179 128.5, 129.1, 130.2, 131.1, 136.7, 146.8, 158.1: MS (m/z, %): 388 (M+
180 100).
,
136.9, 138.4, 146.5 MS (m/z, %): 422 (M+, 100).
225
181 5.2.4. (Table 1, 4e) 2-(4-methoxyphenyl)-1,4,5-triphenyl-1H-imidazole
182
1H NMR, 500 MHz (CDCl3 + DMSO-d6) δ 3.80 (s, 3H), 6.80 (d, J =
5.2.11. (Table 1, 4q) 2-(furan-2-yl)-1,4,5-triphenyl-1H-imidazole
226
183 8.6 Hz, 2H), 7.08 (d, J = 7.0 Hz, 2H), 7.15 (d, J = 7.0 Hz, 2H), 7.21–
184 7.33 (m, 9H), 7.41 (d, J = 8.6 Hz, 2H), 7.64 (d, J = 7.5 Hz, 2 H): 13C
185 NMR (125 MHz, CDCl3) δ 55.6, 114.0, 127.0, 127.9, 128.4, 128.6, 128.7,
186 128.9, 129.5, 130.9, 137.4, 142.2, 160.2: MS (m/z, %): 402 (M+, 100).
1H NMR, 500 MHz (CDCl3 + DMSO-d6) δ 6.45 (d, J = 3.4 Hz, 1H), 227
6.90 (t, J = 4.2 Hz, 1H), 7.17 (t, J = 4.2 Hz, 1H), 7.23–7.27 (m, 7H), 228
7.42–7.50 (m, 8H): 13C NMR (125 MHz, CDCl3/DMSO-d6) δ 126.2, 229
127.1, 127.4, 127.9, 128.3, 129.0, 129.3, 130.0, 130.3, 130.4, 130.8, 230
131.9, 132.1, 133.7, 134.9, 136.9, 137.6, 142.2: MS (m/z, %): 378 (M+), 231
187 5.2.5. (Table 1, 4h) methyl-4-(1,4,5,-triphenyl-1H-imidazole-2-yl)
188 benzoate
189
165, (100).
232
1H NMR, 500 MHz (CDCl3 + DMSO-d6) δ 3.93, (s, 3H), 7.08 (d, J =
6. Uncited references
2Q383
190 7.2 Hz, 2H), 7.16 (d, J = 6.7 Hz, 2H), 7.26–7.37 (m, 9H), 7.55 (d, J =
191 8.3 Hz, 2H), 7.63 (d, J = 7.2 Hz, 2H), 7.94 (d, J = 8.3 Hz, 2H): 13C NMR
192 (125 MHz, CDCl3) δ 52.5, 127.4, 127.9, 128.6, 128.7, 128.8, 129.1,
193 129.7, 129.8, 131.5, 132.0, 145.9, 167.0; MS (m/z, %): 430 (M+, 100).
[48,49,51,52,53,54,55,56,57]
234
References
235
236
194 5.2.6. (Table 1, 4i) 2-(4-nitrophenyl)-1,4,5-triphenyl-1H-imidazole
195
UNCORRECTED PR
[1] J.G. Lambardino, E.H. Wiseman, J. Med. Chem. 17 (1979) 1182.
1H NMR, 500 MHz (CDCl3 + DMSO-d6) δ 7.12 (d, J = 7.3 Hz, 2H),
[2] T.N. Doman, S.L. McGovern, B.J. Witherbee, T.P. Kasten, R. Kurumbail, W.C. Stallings, 237
196 7.17 (d, J = 2 H), 7.24–7.30 (m, 6 H), 7.35–7.42 (m, 3H), 7.62–7.66
197 (m, 4H), 8.12 (d, J = 8.6 Hz, 2 H): 13C NMR (125 MHz, CDCl3) δ 123.8,
198 127.6, 127.8, 128.6, 128.7, 128.9, 129.0, 1129.5, 129.6, 130.0, 131.4,
199 132.8, 136.9: MS (m/z, %): 417 (M+) 165 (100).
D.T. Connolly, B.K. Shoichet, J. Med. Chem. 45 (2002) 2213.
[3] C.A. Blum, X. Zheng, S.D. Lombaert, J. Med. Chem. 47 (2004) 2318.
[4] T. Welton, Chem. Rev. 99 (1999) 2071.
238
239
240
241
242
243
244
[5] W.A. Hermann, C. Kocher, Angew. Chem. Int. Ed. 36 (1997) 2162.
[6] D. Enders, T. Balensiefer, Acc. Chem. Res. 37 (2004) 534.
[7] N. Marion, S. Díez-González, S.P. Nolan, Angew. Chem. Int. Ed. 46 (2007) 2988.
[8] S. Kamijo, Y. Yamamoto, Chem. Asian J. 2 (2007) 568.
[9] K. Nakashima, Y. Fukuzaki, R. Nomura, R. Shimoda, Y. Nakamura, N. Kuroda, S. 245
Akiyama, K. Irgum, Dyes Pigments 38 (1998) 127. 246
[10] F.E. Gostev, L.S. Kol'tsova, A.N. Petrukhin, A.A. Titov, A.I. Shiyonok, N.L. Zaichenko, V. 247
S. Marevtsev, O.M. Sarkisov, J. Photochem. Photobiol. A 156 (2003) 15. 248
[11] L. Zhao, S.B. Li, G.A. Wen, B. Peng, W. Huang, Mater. Chem. Phys. 100 (2006) 460. 249
200 5.2.7. (Table 1, 4j) 1,4,5-triphenyl-2-o-toyl-1H-imidazole
201
1H NMR, 500 MHz (DMSO-d6) δ 2.49 (s, 3H), 7.07–7.16 (m, 3H),
202 7.17–7.30 (m, 14H), 7.49 (d, J = 7.5 Hz, 2H): 13C NMR (125 MHz,
203 DMSO-d6) δ 20.8, 125.9, 127.2, 128.9, 129.0, 129.1, 129.3, 129.5, 129.6,
204 130.4, 130.8, 131.4, 131.7, 131.8, 135.4, 136.9, 137.2, 138.5, 147.3: MS
205 (m/z, %): 386 (M+, 100).
[12] S. Balalaei, A. Arabanian, Green Chem. 2 (2000) 274.
[13] K. Sivakumar, A. Kathirvel, A. Lalitha, Tetrahedron Lett. 51 (2010) 3018.
250
251